Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

November 3, 2018

Study Completion Date

November 30, 2018

Conditions
Gram-negative Bacteremia
Interventions
DEVICE

Accelerate PhenoTest™ BC Kit

Rapid identification and AST using the Accelerate PhenoTest™ BC Kit, performed on the Accelerate Pheno™ System (AXDX)

DEVICE

Standard Culture and AST

Standard culture and antimicrobial susceptibility testing (AST)

Trial Locations (2)

55905

Mayo Clinic, Rochester

90049

University of California, Los Angeles, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Vanderbilt University

OTHER

lead

Duke University

OTHER

NCT03218397 - Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia | Biotech Hunter | Biotech Hunter